These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3011 related items for PubMed ID: 8618433

  • 1. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

  • 2. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE.
    J Immunol; 1996 Oct 01; 157(7):2953-60. PubMed ID: 8816402
    [Abstract] [Full Text] [Related]

  • 3. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG.
    Leukemia; 1996 Feb 01; 10(2):297-310. PubMed ID: 8637239
    [Abstract] [Full Text] [Related]

  • 4. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG, Quentmeier H.
    Leukemia; 1996 Sep 01; 10(9):1405-21. PubMed ID: 8751457
    [Abstract] [Full Text] [Related]

  • 5. Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells.
    Drexler HG, Meyer C, Quentmeier H.
    Leuk Lymphoma; 1999 Mar 01; 33(1-2):83-91. PubMed ID: 10194124
    [Abstract] [Full Text] [Related]

  • 6. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
    Dehmel U, Zaborski M, Meierhoff G, Rosnet O, Birnbaum D, Ludwig WD, Quentmeier H, Drexler HG.
    Leukemia; 1996 Feb 01; 10(2):261-70. PubMed ID: 8637235
    [Abstract] [Full Text] [Related]

  • 7. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
    Stacchini A, Fubini L, Severino A, Sanavio F, Aglietta M, Piacibello W.
    Leukemia; 1996 Oct 01; 10(10):1584-91. PubMed ID: 8847893
    [Abstract] [Full Text] [Related]

  • 8. Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines.
    Dehmel U, Quentmeier H, Drexler HG.
    Leukemia; 1996 Feb 01; 10(2):271-8. PubMed ID: 8637236
    [Abstract] [Full Text] [Related]

  • 9. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V.
    Leukemia; 1990 Aug 01; 4(8):561-6. PubMed ID: 1697011
    [Abstract] [Full Text] [Related]

  • 10. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.
    McKenna HJ, Smith FO, Brasel K, Hirschstein D, Bernstein ID, Williams DE, Lyman SD.
    Exp Hematol; 1996 Feb 01; 24(2):378-85. PubMed ID: 8641369
    [Abstract] [Full Text] [Related]

  • 11. Expression of the flt3 receptor and its ligand on hematopoietic cells.
    Brasel K, Escobar S, Anderberg R, de Vries P, Gruss HJ, Lyman SD.
    Leukemia; 1995 Jul 01; 9(7):1212-8. PubMed ID: 7630197
    [Abstract] [Full Text] [Related]

  • 12. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM, Delwel R, van Buitenen C, Hoogerbrugge H, Löwenberg B.
    Leukemia; 1993 Mar 01; 7(3):426-34. PubMed ID: 7680401
    [Abstract] [Full Text] [Related]

  • 13. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
    Eder M, Hemmati P, Kalina U, Ottman OG, Hoelzer D, Lyman SD, Ganser A.
    Exp Hematol; 1996 Feb 01; 24(2):371-7. PubMed ID: 8641368
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K.
    Exp Hematol; 1995 Aug 01; 23(9):970-7. PubMed ID: 7543418
    [Abstract] [Full Text] [Related]

  • 15. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
    Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG.
    Leukemia; 1995 Aug 01; 9(8):1368-72. PubMed ID: 7643626
    [Abstract] [Full Text] [Related]

  • 16. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S.
    Blood; 1995 Sep 01; 86(5):1661-70. PubMed ID: 7544638
    [Abstract] [Full Text] [Related]

  • 17. Modulation of haematopoietic progenitor development by FLT-3 ligand.
    Banu N, Deng B, Lyman SD, Avraham H.
    Cytokine; 1999 Sep 01; 11(9):679-88. PubMed ID: 10479404
    [Abstract] [Full Text] [Related]

  • 18. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D, Yang YC, Clark SC, Kreider BL, Caracciolo D, Rovera G.
    J Immunol; 1987 Nov 15; 139(10):3348-54. PubMed ID: 3500218
    [Abstract] [Full Text] [Related]

  • 19. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors.
    Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D.
    J Immunol; 1996 Jan 15; 156(2):489-96. PubMed ID: 8543798
    [Abstract] [Full Text] [Related]

  • 20. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
    Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M.
    Blood; 1996 Nov 15; 88(10):3987-97. PubMed ID: 8916965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 151.